What Are LIPO-102 Injections?
In October 2010 a new development in surgical fat reduction was announced. A new fat reducing injection has been developed and tested. LIPO-102 injections contain 2 chemicals to aid lipolsys (fat burning) of abdominal subcutaneous fat (the fat directly beneath the skin). It is important to note that these injections were not given to help reduce visceral fat (the deeper belly fat).
The chemicals in the injections are salmeterol and fluticasone. In the study 60 men and women with a BMI of 18.5 to 28 were injected in a double blind trial (neither the people receiving the injections or those giving the injections knew which needles contained the LIPO-102 and which contained a placebo).
The results showed that in the group who received the injections average waist circumference reduced by 2cm (almost 1 inch) during the 8 week study.
These results were announced during the American Society for Dermatologic Surgery (ASDS) 2010 Annual Meeting on 22nd October 2010.
LIPO-102 Salmeterol Xinafoate (SX) + Fluticasone Propionate (FP)
The presentation was called “Evaluation of LIPO-102 (Salmeterol Xinafoate (SX) + Fluticasone Propionate (FP) for Injection) for the Reduction of Abdominal Subcutaneous Fat” and presented by Adam M. Rotunda, MD.
Adam Rotunda has published previous papers on this topic too. In December 2009 he published a review article in Lasers in Surgery and Medicine called “Injectable treatments for adipose tissue: Terminology, mechanism, and tissue interaction” (Lasers in Surgery and Medicine, Volume 41, Issue 10, pages 714–720, December 2009). He concluded in 2009 that the “mechanism of action and tissue effects of injectable fat reducing compounds are diverse but are becoming increasingly understood.”
These new techniques could essentially be the equivalent of Botox injections for belly fat. The injections will be more widely available that liposuction, and safer too. The method is called mesotherapy and specifically targets skin fat (subcutaneous fat).
However, there is the obvious risk of abuse by non-licensed and unqualified people.